CTNND1 and breast cancer: In the current study, we describe a novel signaling axis in endocrine resistant breast cancer and basal A TNBC involving PKCα, FOXC2, and p120-catenin that promotes cancer cell migration and invasion, which are considered integral steps in EMT.